What’s Happening
Think of it as the ethics police for human research. Every study involving people—whether it’s a quick survey or a major clinical trial—needs IRB sign-off. The rules haven’t changed much lately: if you’re working with human subjects in the U.S., you’re almost certainly on the hook for IRB oversight, whether your project gets NIH funding or not.
What counts as research that needs IRB approval?
That covers just about everything. Surveys, interviews, clinical trials, behavioral studies—if it involves people and isn’t purely observational (like analyzing publicly available data), the IRB wants a say. And here’s the kicker: funding doesn’t matter. Even unfunded projects at your institution need approval.
What training do researchers need before submitting?
Think of this as your research ethics driver’s license. Schools like UCSF won’t let you submit without it. The training usually runs through informed consent, risk assessment, and how to protect participant privacy. Some places even require Good Clinical Practice (GCP) certification these days—especially if you’re running clinical trials.
How do I write a solid IRB protocol?
Start with the basics: what’s the study about, who’s in it, and how will you recruit them? Then spell out exactly what participants will go through. Don’t hide behind jargon—explain it like you’re talking to your grandma. And be brutally honest about risks and benefits. The IRB isn’t looking for perfect studies; they’re looking for studies that won’t harm people.
What should go in the informed consent document?
This isn’t just paperwork—it’s your participants’ lifeline. Make sure they understand what they’re signing up for, that they can leave anytime, and how their data will stay safe. Skip the legalese. The clearer it is, the smoother the approval process goes. And remember: no study procedures can start until every participant signs on the dotted line.
How do I pick the right IRB review type?
Here’s the breakdown:
| Review Type | When Used | Process Time |
|---|---|---|
| Exempt | Studies in approved categories with minimal risk (e.g., anonymous surveys, educational tests) | 1–2 weeks |
| Expedited | Studies with minimal risk not covered under exemptions (e.g., blood samples from healthy volunteers) | 2–4 weeks |
| Full Board | Studies involving more than minimal risk (e.g., clinical trials, vulnerable populations) | 4–8 weeks |
Here’s the twist: if you’re running a multi-site study that isn’t exempt, the NIH now requires a single IRB (sIRB) to streamline oversight. That means one board reviews everything instead of each site having its own.
How do I actually submit my IRB protocol?
Most universities and hospitals use these systems now. Fill out every field—missing details are the #1 cause of delays. Double-check your documents before hitting submit. Once it’s in, the clock starts ticking, and you can’t enroll a single participant until you get that approval letter.
What happens after I submit?
This isn’t a rubber stamp process. They might ask for clarifications, tweaks to your consent form, or adjustments to your risk assessment. Respond quickly—every delay pushes back your timeline. Once they sign off, you’re cleared to start enrolling participants. But remember: no participant contact before that green light.
What if my protocol gets rejected?
Rejections sting, but they’re fixable. First, figure out why it happened. Was your risk level misclassified? Did your consent form miss a required element? Many schools offer “IRB office hours” where you can get feedback before submitting. Use that resource—it saves time in the long run.
How can I avoid common IRB delays?
Here’s the brutal truth: IRB delays are almost always preventable. Start the process 8–12 weeks before you plan to enroll participants. Use your institution’s templates—they’re updated regularly to match current rules. Make sure every team member completes the required training. And keep meticulous records of every email, approval, and amendment. Audits happen, and you’ll want that paper trail.
What’s the deal with exemptions—can I just skip IRB review?
This trips up a lot of researchers. You can’t just assume your retrospective chart review or anonymous survey is exempt. The IRB has to review it first and formally classify it. Don’t start collecting data until you’ve got that written approval in hand. It’s better to be safe than sorry—IRB violations can tank your funding and your reputation.
Why does all this IRB stuff matter anyway?
Look, no one likes bureaucracy. But IRB oversight exists for a reason: to make sure we don’t hurt people in the name of science. A solid protocol review catches problems before they become disasters. It protects your participants, your institution, and your career. So yes, it’s a hassle—but it’s a necessary one. Always check with your local IRB office for the latest rules, because regulations change faster than you’d think.
